MICHELLE KEATING-SIBEL: Open Payments
NPI 1093130940 · LANSDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,350 in 31 payments from 9 companies in 2025. Trend: 2023 $47 · 2024 $1,253 · 2025 $1,350
Food & beverage: $1,350
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $280 |
| Amgen Inc. | 4 | $242 |
| AstraZeneca Pharmaceuticals LP | 4 | $215 |
| Lilly USA, LLC | 6 | $195 |
| GlaxoSmithKline, LLC. | 4 | $144 |
| ABBVIE INC. | 2 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $101 |
| Daiichi Sankyo Inc. | 1 | $27 |
| Abbott Laboratories | 1 | $22 |
Products named: EVENITY, Wegovy, AIRSUPRA, UBRELVY, ZEPBOUND, VOQUEZNA, BREZTRI, AREXVY.
Industry payments across PA — which companies pay providers there.
